ALXN Stock UPDATES Alexion Pharmaceuticals (ALXN) 168.74 08/20/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Alexion Pharmaceuticals (ALXN) 168.74 $ALXN

Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Aug 20, 10:08AM CDT
Last week, hepatitis C virus treatments remained in focus with Achillion and Gilead providing updates on ACH-3102 and Sovaldi, respectively.

Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 19, 4:25PM CDT
Amgen Inc. (AMGN) announced that AMG 416 has met the primary as well as secondary endpoints in the second phase III registration study.

Jazz, Celgene Lead Top 4 Drugmaker Profit Margins
at Investor's Business Daily - Mon Aug 18, 12:46PM CDT
Some of the fattest annual profit margins come from drugmakers whose products are meant to make people healthier. Today's Screen of the Day is Healthy Profit Margin and includes four highly rated drug stocks. Don't miss out on Jazz Pharmaceuticals...

5 Stocks Triggering Big Breakout Trades
at The Street - Mon Aug 18, 10:12AM CDT
These stocks look poised to break out and trade higher from current levels.

SmarTrend Watching for Potential Pullback in Shares of Alexion Pharmaceuticals After 1.42% Gain
Comtex SmarTrend(R) - Fri Aug 15, 3:53PM CDT
Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $167.24 to a high of $171.44. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $169.02 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Stock Market News for August 15, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Aug 15, 9:10AM CDT
Markets ended in the green as Russian president’s comments eased concerns related to geopolitical tensions

Technical Updates, Study Outcomes, Project Approvals, and Quarterly Performance Reviews - Research Reports on Alexion, Novartis, CB&I, L-3 and Emerson
PR Newswire - Fri Aug 15, 7:40AM CDT
Today, Analysts Review released its research reports regarding Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), Novartis AG (NYSE: NVS), Chicago Bridge & Iron Company N.V. (NYSE: CBI), L-3 Communications Holdings Inc. (NYSE: LLL) and Emerson Electric Co. (NYSE: EMR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5765-100free.

Researchers to Present New Data on Asfotase Alfa in Pediatric Patients with Hypophosphatasia at the American Society for Bone and Mineral Research 2014 Annual Meeting
Business Wire - Wed Aug 13, 3:57PM CDT
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that new data from multiple studies of asfotase alfa in pediatric patients with hypophosphatasia (HPP) will be presented at the American Society for Bone and Mineral Research (ASBMR) 2014 Annual Meeting, which takes place September 12-15, 2014 in Houston, Texas. The meeting will feature a late-breaking abstract of survival data in pediatric patients with HPP at high risk of death who were treated with asfotase alfa, along with results from two studies in patients with perinatal, infantile and juvenile HPP who were treated with asfotase alfa for up to three years.

National Association of Professional Women Announces Donna Ames, Sr. Manager, Clinical Project Lead at Alexion Pharmaceuticals, a 2014 Professional Woman of the Year
PRWeb - Mon Aug 11, 11:03PM CDT
NAPW honors Donna Ames as a 2014 Professional Woman of the Year for coordinating clinical trials with this prestigious distinction. As the largest, most-recognized networking organization of women in the country, spanning virtually every industry and profession, the National Association of Professional Women (NAPW) is a powerfully vibrant networking community with over 600,000 members and more than 300 Local Chapters.

Alexion Pharmaceuticals Set to Possibly Pullback After Yesterday's Rally of 1.68%
Comtex SmarTrend(R) - Mon Aug 11, 4:18PM CDT
Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $158.24 to a high of $162.18. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $159.60 on volume of 968,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Cannabis Should Be Treated as an Agricultural Commodity, Not a Biotech Investment
ACCESSWIRE - Mon Aug 11, 1:44PM CDT
Pittsburgh, PA / August 11, 2014 / While the future of cannabusiness is certainly bright, one controversial yet crucial caveat must be made. Pot stocks should be treated as an agricultural commodity investment rather than as a biotech investment. This is not to say that cannabis cannot be used as a pharmaceutical. It certainly can. Rather it should not be invested in as one would invest in a pharmaceutical. Taking a biotech strategy with pot stocks is the wrong road to take.

Earnings Look Back: Alexion Pharmaceuticals Is Down 5.0% Since Reporting Quarterly Results 2 Weeks Ago (ALXN)
Comtex SmarTrend(R) - Mon Aug 11, 12:08PM CDT
Two weeks ago on July 24th, 2014 Alexion Pharmaceuticals (NASDAQ:ALXN) reported earnings and analysts, on average, expected earnings of $1.07 on sales of $510.5 million. The company actually reported EPS of $1.12 on sales of $512.5 million, beating EPS estimates by $0.05 and beating revenue estimates by $2.0 million. Since the company's report, shares of Alexion Pharmaceuticals have fallen from $167.48 to $159.11, representing a loss of 5.0% in the past 18 days.

Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma
PR Newswire - Mon Aug 11, 7:40AM CDT
The trading session on Friday, August 08, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,553.93, up 1.13% and the NASDAQ Composite closed at 4,370.90, up 0.83%. The S&P 500 finished the day 1.15% higher at 1,931.59. The gains were broad based as all the ten sectors finished on a positive note. The S&P 500 Health Care Sector Index finished the day at 699.99, up 1.14%, and the index has advanced 4.73% in the previous three months. Investor-Edge has initiated coverage on the following equities: InterMune Inc. (NASDAQ: ITMN), Biogen Idec Inc. (NASDAQ: BIIB), Insmed Inc. (NASDAQ: INSM), Dendreon Corp. (NASDAQ: DNDN), and Alexion Pharmaceuticals Inc. (NASDAQ: ALXN). Free research on these five companies can be accessed at:

Today's Stocks Driving Success For The Health Care Sector
at The Street - Fri Aug 08, 12:03PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.

VIVUS Reports Narrower-than-Expected Loss on Qsymia Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 10:00AM CDT
VIVUS Inc. (VVUS) reported second quarter 2014 loss (excluding one-time items) of 25 cents per share.

Orexigen Therapeutics Reports Wider Q2 Loss as Costs Mount - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 8:20AM CDT
Orexigen Therapeutics, Inc. (OREX) reported a net loss of 21 cents per share in the second quarter of 2014.

Here's How Facebook, Alexion Teach Lessons In Tenacity
at Investor's Business Daily - Thu Aug 07, 5:02PM CDT
Tenacity is among the more difficult yet more rewarding traits CAN SLIM investors eventually learn to cultivate. Buy-and-hold investors keep a stock as it spirals deep into a correction. They wager on faith that the stock will at some point rise to...

NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 07, 11:40AM CDT
NPS Pharma (NPSP) reported earnings of 2 cents in the second quarter , which compared favorably with the Zacks Consensus Estimate.

Financial Results, FDA Approvals, Orphan Drug Designations, and Certificates - Research Reports on Idenix, Baxter, Alexion, Alere and Zoetis
PR Newswire - Thu Aug 07, 8:10AM CDT
Today, Analysts Review released its research reports regarding Idenix Pharmaceuticals Inc. (NASDAQ: IDIX), Baxter International Inc. (NYSE: BAX), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), Alere Inc. (NYSE: ALR) and Zoetis Inc. (NYSEQ: ZTS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5549-100free.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Blue Diamond's $1 Billion Brand Meets Farm Realities

Updated Category News Views 126

A Ten-Cent Signal Carries Real Weight A ten-cent edge over the industry benchmark may not excite the cocktail-party crowd, but almond growers notice every penny when fertilizer, power and pest control keep gnawing at the farm gate. Blue Diamond Growers says it delivered payments roughly 10 cents above the benchmark in its latest year, alongside net profit that came in...

Continue Reading
A Quanzhou Table Offers China Beyond the Headlines

Updated Category News Views 35

Steam rising from a Quanzhou table can carry more weight than another polished speech about cultural exchange. That is the sensible instinct behind Home Banquets with Master Chefs, the CCTV-4 series using regional meals to explore geography, customs and memory. It is not trying to explain China through a pile of statistics or a museum-label summary. It starts where people...

Continue Reading
Rosengart's Repeat Honor Signals Litigation Bench Depth

Updated Category News Views 196

Hollywood lawsuits rarely stay tucked inside a filing cabinet; they spill into headlines, contracts, careers, and sometimes a company's whole public posture. That is why Mathew S. Rosengart landing on The Hollywood Reporter's Top 25 Legal Troubleshooters list for a second straight year is more than a pleasant plaque for the office wall. It is a reminder that, in media and...

Continue Reading
COSCO Shipping Uses CIIE to Put People in the Chain

Updated Category News Views 87

A Supply Chain Is Not Just Steel and Schedules Containers do not shake hands, but the people routing them certainly do. That was the useful, rather human point underneath COSCO SHIPPING's presence at the ninth China International Import Expo in Shanghai: global logistics is a physical business built on relationships that have to survive different languages, markets,...

Continue Reading
Borr’s Q3 Presentation Puts Jack-Up Investors on Watch

Updated Category News Views 39

Jack-up drilling is a rough business to judge from a calendar invite, but Borr Drilling has put a useful marker in the sand. The company is scheduled to present financial results for the three and nine months ended September 30, 2026, at 09:00 New York time, or 15:00 CET, on Thursday, November 19. For holders of BORR, this is less about ceremonial webcast chatter and more...

Continue Reading
MegaRobo's Nearly $200 Million Bet on Learning Labs

Updated Category News Views 115

A lab robot that merely follows instructions is old news; a system that learns from the mess it makes is the expensive part. MegaRobo has raised nearly US$200 million to push toward that harder prize: infrastructure that links AI reasoning to actual experiments, instruments, automation and the results that come back. For investors watching AI for Science, this is more...

Continue Reading
Health In Tech Gets a Real Distribution Test in 2027

Updated Category News Views 97

A 100,000-employee funnel is the sort of number that makes a small InsurTech investor sit up, then reach for the fine print. Health In Tech has brought a national third-party administrator onto its eDIYBS platform, giving the company access to a TPA serving more than 650 employers in over 40 states, with more than 100,000 covered employees as of May 2026. That is...

Continue Reading
LianLian XWorker Brings AI Agents Into Global Payments

Updated Category News Views 74

Most AI launches promise a clever helper; this one wants the helper holding a tightly controlled wallet. Lianlian DigiTech unveiled LianLian XWorker at Singapore FinTech Festival 2026 on November 19, pitching an AI Workforce platform that joins task-running agents with its global financial plumbing. That is a much more consequential proposition than another chatbot that...

Continue Reading
ROHM's GaN PFC Chip Targets the Power-Supply Squeeze

Updated Category News Views 48

Power supplies are where a lot of sleek electronics quietly lose the plot, and ROHM is taking a proper swing at that problem. Its new BM85060FV is a totem-pole power factor correction controller built for gallium nitride, or GaN, high-frequency switching in AC-DC power supplies. The headline is not subtle: ROHM says a 300 to 500 W system using the chip can reach 99%...

Continue Reading
Frosty Animatronics Put Nostalgia on Lowe's Shelves

Updated Category News Views 142

A moving corncob pipe is not anybody's idea of a macroeconomic signal, yet holiday aisles are built on precisely these little jolts of recognition. Gemmy has teamed with Warner Bros. Discovery Global Consumer Products to place a new animated Frosty the Snowman collection exclusively at Lowe's for the 2026 holiday season. It is cheerful retail business, not earthshaking...

Continue Reading

Top 5 Most Recently Viewed Articles

Business Jet Steals the Spotlight with Starlink Installation

Updated Category News Views 350

Business Jet Achieves Significant Milestone with Starlink Business Jet has proudly completed the first installation of Starlink on the Embraer Legacy 600 certification aircraft. This innovative achievement signifies a major step in enhancing the inflight connectivity experience for clients, marking the Legacy 600 as a pioneer aircraft equipped with Starlink capabilities....

Continue Reading
Understanding the Importance of Snow Removal for Roof Safety

Updated Category News Views 166

Understanding the Importance of Roof Snow Removal When it comes to maintaining the safety of your home during winter, one crucial task often overlooked is roof snow removal. Roofing expert John Kolarik from Mariage Roofing shares valuable insights on why homeowners should be proactive about this important aspect of winter maintenance. Removing snow from roofs not only...

Continue Reading
Teck Resources Plans Significant Share Buyback Initiative

Updated Category News Views 126

Teck Resources Limited's Normal Course Issuer Bid Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) has exciting news as it prepares to initiate a normal course issuer bid aimed at repurchasing its Class B subordinate voting shares. With the Toronto Stock Exchange’s approval, Teck is set to purchase up to 40 million of these shares, equating to roughly 7.9% of...

Continue Reading
SR Bancorp Sees Fluctuations in Quarterly Income Performance

Updated Category News Views 192

Introduction to SR Bancorp, Inc. SR Bancorp, Inc. (NASDAQ: SRBK), the holding company for Somerset Regal Bank, has recently published its quarterly financial results, reflecting changes in net income and asset growth. In the most recent quarter, the company demonstrated resilience and adaptability amidst fluctuating market conditions. Net Income Overview Financial Results...

Continue Reading
Reddit Inc's Stock Surges: Navigating Mispricing and Strategies

Updated Category News Views 146

Reddit Inc Experiences Remarkable Stock Surge After being under pressure for much of the spring, shares of Reddit Inc (NYSE: RDDT) have rebounded dramatically. The stock experienced a surge of over 50% within a span of just two weeks, decisively breaking out of its previous trading range and reaching all-time highs. This notable rebound is striking, especially considering...

Continue Reading